{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:30:56Z","timestamp":1773898256505,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-024-05653-x","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T13:02:00Z","timestamp":1720443720000},"page":"2555-2559","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Plasminogen activator inhibitor-1 genotype 4G\/5G associates with skin involvement in Armenian familial Mediterranean fever patients"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2768-795X","authenticated-orcid":false,"given":"Gernot","family":"Kriegsh\u00e4user","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0162-2680","authenticated-orcid":false,"given":"Hasmik","family":"Hayrapetyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4126-848X","authenticated-orcid":false,"given":"Christian","family":"Oberkanins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4767-7567","authenticated-orcid":false,"given":"Tamara","family":"Sarkisian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,8]]},"reference":[{"key":"5653_CR1","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0140-6736(97)09408-7","volume":"351","author":"E Ben-Chetrit","year":"1998","unstructured":"Ben-Chetrit E, Levy M (1998) Familial Mediterranean fever. Lancet 351:659\u2013664","journal-title":"Lancet"},{"key":"5653_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/13506129908993281","volume":"6","author":"A Livneh","year":"1999","unstructured":"Livneh A, Langevitz P, Shinar Y, Zaks DL, Kastner M, Pras M et al (1999) MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid 6:1\u20136","journal-title":"Amyloid"},{"key":"5653_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/sj.ejhg.5200170","volume":"6","author":"M Dewalle","year":"1998","unstructured":"Dewalle M, Domingo C, Rozenbaum M, Ben-Ch\u00e9trit E, Cattan D, Bernot A et al (1998) Phenotype-genotype correlation in jewish patients suffering from familial Mediterranean fever (FMF). Eur J Hum Genet 6:95\u201397","journal-title":"Eur J Hum Genet"},{"key":"5653_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/sj.ejhg.5200303","volume":"7","author":"M Shohat","year":"1999","unstructured":"Shohat M, Magal N, Shohat T, Chen X, Dagan T, Mimouni A et al (1999) Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis. Eur J Hum Genet 7:287\u2013292","journal-title":"Eur J Hum Genet"},{"key":"5653_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/sj.ejhg.5200776","volume":"10","author":"R Gershoni-Baruch","year":"2002","unstructured":"Gershoni-Baruch R, Brik R, Shinawi M, Livneh A (2002) The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever. Eur J Hum Genet 10:145\u2013149","journal-title":"Eur J Hum Genet"},{"key":"5653_CR6","doi-asserted-by":"publisher","first-page":"574593","DOI":"10.3389\/fimmu.2020.574593","volume":"11","author":"A Stella","year":"2020","unstructured":"Stella A, Lamkanfi M, Portincasa P (2020) Familial Mediterranean Fever and COVID-19: friends or foes? Front Immunol 11:574593","journal-title":"Front Immunol"},{"key":"5653_CR7","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1046\/j.1538-7836.2003.00261.x","volume":"1","author":"CT Esmon","year":"2003","unstructured":"Esmon CT (2003) Inflammation and thrombosis. J Thromb Haemost 1:1343\u20131348","journal-title":"J Thromb Haemost"},{"key":"5653_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00431-007-0475-2","volume":"167","author":"A Demirel","year":"2008","unstructured":"Demirel A, Celkan T, Kasapcopur O, Bilgen H, Ozkan A, Apak H et al (2008) Is familial Mediterranean Fever a thrombotic disease or not? Eur J Pediatr 167:279\u2013285","journal-title":"Eur J Pediatr"},{"key":"5653_CR9","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1177\/1076029608325540","volume":"15","author":"DO Demiralp","year":"2009","unstructured":"Demiralp DO, Ekim M, Akar N (2009) The effect of plasminogen activator Inhibitor-1 -675 4G\/5G polymorphism on familial Mediterranean Fever (FMF) Disease. Clin Appl Thromb Hemost 15:443\u2013447","journal-title":"Clin Appl Thromb Hemost"},{"key":"5653_CR10","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/(SICI)1096-8628(19980113)75:2<216::AID-AJMG20>3.0.CO;2-R","volume":"75","author":"E Pras","year":"1998","unstructured":"Pras E, Livneh A, Balow JE Jr, Pras E, Kastner M, Pras M et al (1998) Clinical differences between north African and Iraqui jews with familial Mediterranean fever. Am J Med Genet 75:216\u2013219","journal-title":"Am J Med Genet"},{"key":"5653_CR11","first-page":"1959","volume":"136","author":"S Jiang","year":"2023","unstructured":"Jiang S, Wang Y, Chen L, Mu H, Meaney C, Fan Y et al (2023) PAI-1 genetic polymorphisms influence septic patients\u00b4 outcomes by regulating neutrophil activity. Chin Med J 136:1959\u20131966","journal-title":"Chin Med J"},{"key":"5653_CR12","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1161\/ATVBAHA.117.309760","volume":"38","author":"M Praetner","year":"2018","unstructured":"Praetner M, Zuchtriegel G, Holzer M, Uhl B, Schaub\u00e4cher J, Mittmann L et al (2018) Plasminogen activator inhibitor-1 promotes neutrophil infiltration and tissue injury on ischemia-reperfusion. Arterioscler Thromb Vasc Biol 38:829\u2013842","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5653_CR13","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1182\/blood-2006-05-025197","volume":"109","author":"R Renckens","year":"2007","unstructured":"Renckens R, Roelofs JJTH, Bonta PI, Florquin S, de Vries CJM, Levi M et al (2007) Plasminogen activator inhibitor type 1 is protectiveduring severe gram-negative pneumonia. Blood 109:1593\u20131601","journal-title":"Blood"},{"key":"5653_CR14","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1073\/pnas.92.6.1851","volume":"92","author":"P Eriksson","year":"1995","unstructured":"Eriksson P, Kallin B, van \u2018t Hooft FM, Bavenholm P, Hamsten A (1995) Allele-specific increase in basal transcription of the plasminogen activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 92:1851\u20131855","journal-title":"Proc Natl Acad Sci USA"},{"key":"5653_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1024\/0301-1526\/a000839","volume":"49","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Jin Y, Li X, Peng X, Song J, Xu M (2020) Plasminogen activator inhibitor-1(PAI-1) 4G\/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review. Vasa 49:141\u2013146","journal-title":"Vasa"},{"key":"5653_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejogrb.2013.12.030","volume":"175","author":"YH Lee","year":"2014","unstructured":"Lee YH, Song GG (2014) Plasminogen activator inhibitor-1 4G\/5G and the MTHFR 677\u00a0C\/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis. Eur J Obstet Gynecol Reprod Biol 175:8\u201314","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"5653_CR17","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/j.1365-2222.2009.03272.x","volume":"39","author":"Z Ma","year":"2009","unstructured":"Ma Z, Paek D, Oh CK (2009) Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation. Clin Exp Allergy 39:1136\u20131144","journal-title":"Clin Exp Allergy"},{"key":"5653_CR18","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1056\/NEJMoa021445","volume":"347","author":"Y Yamada","year":"2002","unstructured":"Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H (2002) Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347:1916\u20131923","journal-title":"N Engl J Med"},{"key":"5653_CR19","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1111\/iwj.13480","volume":"17","author":"Y Gao","year":"2020","unstructured":"Gao Y, Jin H (2020) Plasminogen activator inhibitor-1: a potential etiological role in livedoid vasculopathy. Int Wound J 17:1902\u20131908","journal-title":"Int Wound J"},{"key":"5653_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/s10165-012-0687-9","volume":"23","author":"M Dundar","year":"2012","unstructured":"Dundar M, Kiraz A, Balta B, Emirogullar EF, Zararsiz G, Yurci A et al (2012) The role of TNF-\u03b1 and PAI-1 gene polymorphisms in familial Mediterranean fever. Mod Rheumatol 23:140\u2013145","journal-title":"Mod Rheumatol"},{"key":"5653_CR21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11033-007-9106-2","volume":"35","author":"DMR Shammaa","year":"2008","unstructured":"Shammaa DMR, Sabbagh AS, Taher AT, Zaatari GS, Mahfouz RAR (2008) Plasminogen activator Inhibitor-1 (PAI-1) gene 4G\/5G alleles frequency distribution in the Lebanese population. Mol Biol Rep 35:453\u2013457","journal-title":"Mol Biol Rep"},{"issue":"94","key":"5653_CR22","first-page":"S15","volume":"33","author":"E Ben-Chetrit","year":"2015","unstructured":"Ben-Chetrit E, Hayrapetyan H, Yegiazaryan A, Shahsuvaryan G, Sarkisian T (2015) Familial Mediterranean fever in Armenia in 2015: some interesting lessons. Clin Exp Rheumatol 33(94):S15\u2013S18","journal-title":"Clin Exp Rheumatol"},{"key":"5653_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00431-012-1844-z","volume":"172","author":"M Bonyadi","year":"2013","unstructured":"Bonyadi M, Shaghaghi Z, Haghi M, Dastgiri S (2013) Plasminogen activator inhibitor-1 polymorphism in Iranian Azeri Turkish patients with FMF disease and its association with amyloidosis. Eur J Pediatr 172:91\u201398","journal-title":"Eur J Pediatr"},{"key":"5653_CR24","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1590\/S0066-782X2011005000110","volume":"97","author":"LM Lima","year":"2011","unstructured":"Lima LM, Carvalho MDS, Neto CPF, Garcia JCF, Sousa MO (2011) PAI-1 4G\/5G polymorphism and plasma levels association in patients with coronary artery disease. Arq Bras Cardiol 97:462\u2013467","journal-title":"Arq Bras Cardiol"},{"key":"5653_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0300-8932(09)70893-0","volume":"62","author":"I Isordia-Salas","year":"2009","unstructured":"Isordia-Salas I, Lea\u00f1os-Miranda A, Sainz IM, Reyes-Maldonado E, Borrayo-Sanchez G (2009) Association of the plasminogen activator inhibitor-1 gene 4G\/5G polymorphism with ST elevation acute myocardial in-farction in young patients. Rev Esp Cardiol 62:365\u2013372","journal-title":"Rev Esp Cardiol"},{"key":"5653_CR26","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/oby.2006.85","volume":"14","author":"JB Meigs","year":"2006","unstructured":"Meigs JB, Dupuis J, Liu C, Donnell CJ, Fox CS, Kathiresan S et al (2006) PAI-1 gene 4G\/5G polymorphism and risk of type 2 diabetes in a population-based sample. Obesity 14:753\u2013758","journal-title":"Obesity"},{"key":"5653_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1161\/01.CIR.101.1.67","volume":"101","author":"M Roest","year":"2000","unstructured":"Roest M, van der Schouw YT, Banga JD, Tempelman MJ, Groot PG, Sixma JJ (2000) Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women. Circulation 101:67\u201370","journal-title":"Circulation"},{"key":"5653_CR28","doi-asserted-by":"publisher","first-page":"e9136","DOI":"10.1371\/journal.pone.0009136","volume":"5","author":"P Bentley","year":"2010","unstructured":"Bentley P, Peck G, Smeeth L, Whittaker J, Sharma P (2010) Causal relationship of susceptibility genes to ischemic stroke: comparison to ischemic heart disease and biochemical determinants. PLoS ONE 5:e9136","journal-title":"PLoS ONE"},{"key":"5653_CR29","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1161\/hs1101.098150","volume":"32","author":"AP Reiner","year":"2001","unstructured":"Reiner AP, Schwartz SM, Frank MB, Longstreth WT, Hindorff LA, Teramura G (2001) Polymorphisms of coagulation factor XIII subunit A and risk of nonfatal hemorrhagic stroke in young white women. Stroke 32:2580\u20132586","journal-title":"Stroke"},{"key":"5653_CR30","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1161\/01.STR.0000098004.26252.EB","volume":"34","author":"T Hoekstra","year":"2003","unstructured":"Hoekstra T, Geleijinse JM, Kluft C, Giltay EJ, Kok FJ, Schouten EG (2003) 4G-4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly. Stroke 34:2822\u20132828","journal-title":"Stroke"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05653-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05653-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05653-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T21:25:54Z","timestamp":1727299554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05653-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,8]]},"references-count":30,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["5653"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05653-x","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,8]]},"assertion":[{"value":"29 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local institutional review board (IRB), Center of Medical Genetics and Primary Healthcare, Yerevan, Armenia and is in accordance with the latest version of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"All patients provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no conflicts of interest. No part of the work is copied or published elsewhere in whole or in part in any languages.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}